Sign In
Buy ROG
$148.00
-6.22 (-4.03%)
At Close: Jun 03, 2026
FDA approves Roche’s Evrysdi for use in babies under two months with spinal muscular atrophy (SMA)
05:00am, Tuesday, 31'st May 2022 GlobeNewswire Inc.
Basel, 31 May 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved a label extension for Evrysdi® (risdiplam) to include babies un
Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting
12:54pm, Sunday, 29'th May 2022 MarketWatch
This includes Arcellx, Iovance Biotherapeutics, and ZymeWorks.
New pivotal data demonstrate clinical benefit of Roche’s glofitamab, a potential first-in-class bispecific antibody for people with aggressive lymphoma
05:00am, Friday, 27'th May 2022 GlobeNewswire Inc.
Basel, 27 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new pivotal data on its investigational CD20xCD3 T-cell engaging bispecific antibody, glofitamab, will be presented for the
Roche’s Polivy combination approved by European Commission for people with previously untreated diffuse large B-cell lymphoma
03:48pm, Wednesday, 25'th May 2022 GlobeNewswire Inc.
Basel, 25 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission (EC) has granted approval of Polivy® (polatuzumab vedotin) in combination with MabThera®(rituxima
Roche develops unique PCR tests to detect the monkeypox virus
03:45pm, Wednesday, 25'th May 2022 GlobeNewswire Inc.
Basel, 25 May 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed three unique LightMix® Modular Virus kits in response to recent monkeypox virus concerns. Multi
Roche développe des tests PCR de détection du virus de la variole simienne
03:45pm, Wednesday, 25'th May 2022 GlobeNewswire Inc.
Bâle, le 25 mai 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) et sa filiale TIB Molbiol ont développé trois kits LightMix® Modular Virus en réponse aux cas d’infection par le virus de la variole
Roche entwickelt einzigartige PCR-Tests zur Erkennung des Affenpockenvirus
03:45pm, Wednesday, 25'th May 2022 GlobeNewswire Inc.
Basel, 25. Mai 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) und ihre Tochtergesellschaft TIB Molbiol haben in Reaktion auf die jüngste Besorgnis über das Affenpockenvirus drei einzigartige LightMix®
Data at the 2022 ASCO Annual Meeting highlight Roche’s continued commitment to innovation in oncology and personalised healthcare
05:00am, Tuesday, 24'th May 2022 GlobeNewswire Inc.
Basel, 24 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from clinical trials of 18 approved and investigational medicines across more than 20 cancer types will be present
‘I chose to take a gamble’: Husband-wife lab researchers admit taking Pfizer vaccine data to develop their own cancer treatment
11:28pm, Sunday, 22'nd May 2022 MarketWatch
The plot unraveled after Chenyan Wu was caught trying to sneak toxic chemicals into the U.S. from China to start a lab in San Diego.
Is FlexShares International Quality Dividend ETF (IQDF) a Strong ETF Right Now?
10:20am, Tuesday, 17'th May 2022 Zacks Investment Research
Smart Beta ETF report for IQDF
Should You Invest in the Invesco S&P SmallCap Information Technology ETF (PSCT)?
10:20am, Thursday, 12'th May 2022 Zacks Investment Research
Sector ETF report for PSCT
Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure
05:00am, Thursday, 12'th May 2022 GlobeNewswire Inc.
Basel, 12 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Global Fund to Fight AIDS, Tuberculosis and Malaria are joining forces to build and strengthen diagn
Roche pledges to extend commitment to the World Federation of Hemophilia Humanitarian Aid Program to 2028
05:00am, Tuesday, 10'th May 2022 GlobeNewswire Inc.
Basel, 10 May 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has extended its commitment to the World Federation of Hemophilia (WFH) Humanitarian Aid Program until the end of 2028
Should iShares S&P SmallCap 600 Growth ETF (IJT) Be on Your Investing Radar?
10:20am, Monday, 02'nd May 2022 Zacks Investment Research
Style Box ETF report for IJT
New three-year data for Roche’s Evrysdi (risdiplam) show long-term improvements in survival and motor milestones in babies with Type 1 spinal muscular atrophy (SMA)
05:00am, Friday, 29'th Apr 2022 GlobeNewswire Inc.
Basel, 29 April 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new three-year data from the FIREFISH study, including one-year data from the open label extension, reinforcing the long-term
